ArticleCancer immunology research2019

Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development.

Xun Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.